0001864317-23-000001.txt : 20230926
0001864317-23-000001.hdr.sgml : 20230926
20230926180128
ACCESSION NUMBER: 0001864317-23-000001
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230926
FILED AS OF DATE: 20230926
DATE AS OF CHANGE: 20230926
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Katzoff David J
CENTRAL INDEX KEY: 0001864317
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40483
FILM NUMBER: 231281447
MAIL ADDRESS:
STREET 1: 201 SHIPYARD WAY
CITY: NEWPORT BEACH
STATE: CA
ZIP: 92663
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Alzamend Neuro, Inc.
CENTRAL INDEX KEY: 0001677077
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 811822909
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0430
BUSINESS ADDRESS:
STREET 1: 3500 LENOX RD. NE
STREET 2: SUITE 1500
CITY: ATLANTA
STATE: GA
ZIP: 30326
BUSINESS PHONE: 844-722-6333
MAIL ADDRESS:
STREET 1: 3500 LENOX RD. NE
STREET 2: SUITE 1500
CITY: ATLANTA
STATE: GA
ZIP: 30326
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0508
4
2023-09-26
0
0001677077
Alzamend Neuro, Inc.
ALZN
0001864317
Katzoff David J
940 SOUTH COAST DRIVE SUITE 200
COSTA MESA
CA
92626
0
1
0
0
Chief Financial Officer
0
Common Stock
2023-09-26
4
P
0
53000
0.1931
A
81000
D
The common stock was bought by the reporting person in open market transactions on the transaction date, with a volume weighted average sale price of $0.1931. The range of purchase prices on the transaction date was $0.19 to $0.1955 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares bought at each price.
/s/ David J Katzoff
2023-09-26